Is stem cell therapy for Spinal Cord Injury FDA-approved?
No generic stem-cell or exosome product is FDA-approved to restore function after spinal cord injury. An IND, trial listing, surgical technique or facility credential is not marketing approval.
How stem cells are studied for Spinal Cord Injury
Spinal cord injury varies by neurological level, completeness, cause and time since injury. Research includes neural progenitors, oligodendrocyte-lineage products, MSCs, scaffolds and exosomes with different goals and risks. An injection near or into the spinal cord does not establish cell survival, circuit integration, restored walking or recovery of bladder and bowel function.
Am I a candidate? → · Spinal Cord Injury: full overview → · Spinal Cord Injury cost → · Cost →
Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.
Sources & further reading
More on this condition
- Spinal Cord Injury: cell-therapy evidence and registered trials
- How much does stem cell therapy for Spinal Cord Injury cost? (2026)
- Spinal Cord Injury stem cell therapy — your questions answered (2026)
- Spinal Cord Injury: cell-therapy evidence by therapy class
- MSC vs HSCT for Spinal Cord Injury: what the registries show